Abstract
Efficacy and Safety of MSCs Plus Basiliximab for the Treatment of Steroid-Resistant aGVHD after Haploidentical Stem Cell Transplantation: A Multicenter, Randomized, Open-Label Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have